Newsroom
Dr. Rafael Rosell to lead the lung cancer unit at Hospital Quirón Teknon
Pangaea becomes the first laboratory in Spain to achieve accredition for analysis of genetic mutations in liquid biopsy samples
Pangaea investigators, co-authors of results presented at ASCO 2016
More Articles...
- Cancer Research Technology and Pangaea Biotech sign license agreement to develop new cancer drugs
- Guardant Health, Pangaea Biotech, the Dr. Rosell Oncology Institute and MedSIR Announce a Strategic Collaboration to Study Liquid Biopsy in Spain
- DiaCarta and Pangaea Biotech Join Forces to Launch Non-Invasive Tests to Detect Genetic Mutations in Blood from Cancer Patients
- Expert researchers from Pangaea Biotech, co-authors of results presented at AACR 2016
Follow us
